{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:58:04Z","timestamp":1792803484991,"version":"4.5.0"},"reference-count":244,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006005","name":"Agence de la Biom\u00e9decine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.autrev.2021.102755","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T22:30:39Z","timestamp":1611009039000},"page":"102755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Mesenchymal stromal cells for systemic sclerosis treatment"],"prefix":"10.1016","volume":"20","author":[{"given":"Dominique","family":"Farge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Loisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Lansiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102755_bb0005","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"Immunotarget Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/kel189","article-title":"Impact of pain in health related quality of life of patients with systemic sclerosis","volume":"45","author":"Georges","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102755_bb0020","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24676","article-title":"Health-related quality of life in systemic sclerosis: a systematic review","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0030","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0035","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102755_bb0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41584-018-0062-0","article-title":"Major lung complications of systemic sclerosis","volume":"14","author":"Denton","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.autrev.2021.102755_bb0050","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0055","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0060","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/annrheumdis-2016-210503","article-title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)","volume":"76","author":"Herrick","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0065","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.autrev.2021.102755_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102755_bb0075","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.autrev.2021.102755_bb0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma\u2014where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102755_bb0085","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3899\/jrheum.081212","article-title":"Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring","volume":"36","author":"Launay","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.autrev.2021.102755_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrrheum.2018.34","article-title":"Systemic sclerosis: autologous HSCT is efficacious, but can we make it safer?","volume":"14","author":"Burt","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0100","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp Hematol"},{"key":"10.1016\/j.autrev.2021.102755_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0110","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","article-title":"Immunological characterization of multipotent mesenchymal stromal cells\u2014the International Society for Cellular Therapy (ISCT) working proposal","volume":"15","author":"Krampera","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","article-title":"International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials","volume":"18","author":"Galipeau","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0120","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name!","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2021.102755_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00109-019-01776-y","article-title":"Current understanding of the immunosuppressive properties of mesenchymal stromal cells","volume":"97","author":"de Castro","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.autrev.2021.102755_bb0135","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3389\/fimmu.2018.02938","article-title":"Mesenchymal stem cells in systemic sclerosis: allogenic or autologous approaches for therapeutic use?","volume":"9","author":"Rozier","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","article-title":"Update on mesenchymal stem cell-based therapy in lupus and scleroderma","volume":"17","author":"Cras","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41584-018-0099-0","article-title":"New insights into the genetics and epigenetics of systemic sclerosis","volume":"14","author":"Angiolilli","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0150","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0155","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0160","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"Lopez-Isac","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.102755_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/sji.12595","article-title":"Epigenetics: the future direction in systemic sclerosis","volume":"86","author":"Walczyk","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0170","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00439-011-1137-z","article-title":"Unraveling the genetic component of systemic sclerosis","volume":"131","author":"Martin","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2021.102755_bb0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102755_bb0180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102755_bb0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0190-9622(80)80396-3","article-title":"Capillary alterations in scleroderma","volume":"2","author":"Fleischmajer","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102755_bb0210","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0215","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/art.40455","article-title":"Skin gene expression is prognostic for the trajectory of skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"70","author":"Stifano","year":"2018","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0220","first-page":"1202","article-title":"Macrophage infiltration in the skin of patients with systemic sclerosis","volume":"19","author":"Ishikawa","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"Kr\u00e4ling","year":"1995","journal-title":"Pathobiology"},{"key":"10.1016\/j.autrev.2021.102755_bb0230","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13417","article-title":"Novel insights into dendritic cells in the pathogenesis of systemic sclerosis","author":"Carvalheiro","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0240","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor \u03b2-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0245","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00281-015-0509-1","article-title":"The role of the acquired immune response in systemic sclerosis","volume":"37","author":"Chizzolini","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2021.102755_bb0250","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BOR.0000000000000553","article-title":"T cells and cytokines in systemic sclerosis","volume":"30","author":"Fuschiotti","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0255","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/BOR.0b013e32830c45ae","article-title":"T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis","volume":"20","author":"Chizzolini","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: new evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102755_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214202","article-title":"Autoantibodies are present before the clinical diagnosis of systemic sclerosis","volume":"14","author":"Burbelo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0270","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fimmu.2018.01702","article-title":"Innate immunity in systemic sclerosis fibrosis: recent advances","volume":"9","author":"Laurent","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0275","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/annrheumdis-2019-215770","article-title":"Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures","volume":"78","author":"Assassi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0280","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.autrev.2021.102755_bb0290","article-title":"Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile","author":"Skaug","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89073","article-title":"Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity","volume":"1","author":"Lofgren","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2021.102755_bb0300","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","article-title":"Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis","volume":"17","author":"Bhattacharyya","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0305","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/BOR.0000000000000542","article-title":"Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy","volume":"30","author":"Brown","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2019.02.010","article-title":"Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis","author":"Korman","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/j.autrev.2021.102755_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-011-0215-5","article-title":"Dendritic cells: novel players in fibrosis and scleroderma","volume":"14","author":"Lu","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.102755_bb0325","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0330","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0335","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0340","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/art.37706","article-title":"Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis","volume":"65","author":"Fuschiotti","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0345","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.11080","article-title":"Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients","volume":"48","author":"Luzina","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semarthrit.2008.10.009","article-title":"Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature","volume":"40","author":"Kowal-Bielecka","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0355","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/annrheumdis-2018-214382","article-title":"Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib","volume":"78","author":"Ricard","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0365","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf5307","article-title":"T follicular helper\u2013like cells contribute to skin fibrosis","volume":"10","author":"Taylor","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0370","series-title":"Systemic sclerosis - an update on the aberrant immune system and clinical features","article-title":"Cytokines in systemic sclerosis: focus on IL-17","author":"Baraut","year":"2012"},{"key":"10.1016\/j.autrev.2021.102755_bb0375","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","article-title":"IL-17A dissociates inflammation from fibrogenesis in systemic sclerosis","volume":"140","author":"Dufour","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","volume":"195","author":"Chizzolini","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2021.102755_bb0385","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0000000000000218","article-title":"Update on macrophages and innate immunity in scleroderma","volume":"27","author":"Chia","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0390","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0395","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","article-title":"Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions","volume":"71","author":"Mathian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0400","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0410","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2010.09633.x","article-title":"Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea","volume":"162","author":"Antiga","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0415","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","article-title":"Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity","volume":"261","author":"Slobodin","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/bmt.2013.202","article-title":"Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study","volume":"49","author":"Baraut","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.autrev.2021.102755_bb0425","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0430","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0435","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.102755_bb0440","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0445","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb0450","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0455","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2006.06.001","article-title":"Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis","volume":"5","author":"Verrecchia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102755_bb0460","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","article-title":"Scleroderma: from cell and molecular mechanisms to disease models","volume":"26","author":"Abraham","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0465","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u03b2\u2014at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb0470","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","article-title":"Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy","volume":"10","author":"Wei","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102755_bb0475","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","article-title":"Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) Mesenchymal Stromal Cell committee position statement on nomenclature","volume":"21","author":"Viswanathan","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","article-title":"Mechanisms of mesenchymal stem\/stromal cell function","volume":"7","author":"Spees","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0485","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2021.102755_bb0495","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/eji.200738129","article-title":"IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease","volume":"38","author":"Polchert","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0500","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0505","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","article-title":"Biological functions of mesenchymal stem cells and clinical implications","volume":"76","author":"Naji","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2021.102755_bb0510","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2021.102755_bb0515","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/scrt214","article-title":"Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application","volume":"4","author":"Menard","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0520","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.2010.197","article-title":"Good manufacturing practices production of mesenchymal stem\/stromal cells","volume":"22","author":"Sensebe","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0525","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.autrev.2021.102755_bb0530","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0535","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/scrt214","article-title":"Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application","volume":"4","author":"Menard","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0540","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","article-title":"MSC-based product characterization for clinical trials: an FDA perspective","volume":"14","author":"Mendicino","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2021.102755_bb0545","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.autrev.2021.102755_bb0550","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.autrev.2021.102755_bb0555","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0560","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0565","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.stemcr.2016.05.011","article-title":"No identical \u201cmesenchymal stem cells\u201d at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels","volume":"6","author":"Sacchetti","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0570","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14653240802582075","article-title":"Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression","volume":"11","author":"Montesinos","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0575","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1749-6632.2012.06551.x","article-title":"Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets","volume":"1266","author":"Sivasubramaniyan","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2021.102755_bb0580","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/scrt336","article-title":"Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells","volume":"4","author":"Ribeiro","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0585","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3324\/haematol.2009.006171","article-title":"Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors","volume":"94","author":"Avanzini","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2021.102755_bb0590","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.117.311400","article-title":"Mitochondrial oxidative stress reduces the immunopotency of mesenchymal stromal cells in adults with coronary artery disease","volume":"122","author":"Kizilay Mancini","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2021.102755_bb0595","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue\u2010derived adult stem cells: comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2021.102755_bb0600","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/stem.3077","article-title":"Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells","volume":"38","author":"Menard","year":"2020","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0605","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jcyt.2017.03.001","article-title":"Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord","volume":"19","author":"Araujo","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0610","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1574888X11308010012","article-title":"Human Wharton\u2019s jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy","volume":"8","author":"La Rocca","year":"2013","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0615","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.placenta.2017.04.003","article-title":"Immunomodulatory properties of human placental mesenchymal stem\/stromal cells","volume":"59","author":"Abumaree","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.autrev.2021.102755_bb0620","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","article-title":"Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells","volume":"26","author":"Weiss","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0625","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/scd.2018.0132","article-title":"Human Wharton\u2019s jelly mesenchymal stem cells show unique gene expression compared with bone marrow mesenchymal stem cells using single-Cell RNA-sequencing","volume":"28","author":"Barrett","year":"2019","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2021.102755_bb0630","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cyto.a.23242","article-title":"Isolation, cultivation, and characterization of human mesenchymal stem cells","volume":"93","author":"Mushahary","year":"2018","journal-title":"Cytometry A"},{"key":"10.1016\/j.autrev.2021.102755_bb0635","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/stem.2580","article-title":"Brief report: proteasomal indoleamine 2,3-dioxygenase degradation reduces the immunosuppressive potential of clinical grade-mesenchymal stromal cells undergoing replicative senescence","volume":"35","author":"Loisel","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0640","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/bloodadvances.2017006205","article-title":"Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFN\u03b3 priming","volume":"1","author":"Chinnadurai","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.autrev.2021.102755_bb0645","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved mesenchymal stromal cells are susceptible to T-cell mediated apoptosis which is partly rescued by IFN\u03b3 licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0650","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0655","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcyt.2014.06.008","article-title":"Clinical mesenchymal stromal cell products undergo functional changes in response to freezing","volume":"17","author":"Pollock","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0660","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0665","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.tp.0000244572.24780.54","article-title":"Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle","volume":"83","author":"Ramasamy","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2021.102755_bb0670","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0675","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0680","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.4049\/jimmunol.1002239","article-title":"Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation","volume":"185","author":"Cutler","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0685","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-3083.2008.02180.x","article-title":"Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance","volume":"68","author":"Wang","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0690","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0695","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0700","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exphem.2007.11.007","article-title":"Mesenchymal cells recruit and regulate T regulatory cells","volume":"36","author":"Di Ianni","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.autrev.2021.102755_bb0705","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt75","article-title":"Mesenchymal stem cell effects on T-cell effector pathways","volume":"2","author":"Duffy","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0710","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","article-title":"Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction","volume":"92","author":"Prevosto","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2021.102755_bb0715","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0720","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fimmu.2017.01042","article-title":"Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function","volume":"8","author":"Luk","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0725","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.2014.0155","article-title":"Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells","volume":"24","author":"Rosado","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2021.102755_bb0730","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.0902023","article-title":"Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression","volume":"184","author":"Ren","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0735","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stemcr.2017.02.008","article-title":"CD54-mediated interaction with pro-inflammatory macrophages increases the immunosuppressive function of human mesenchymal stromal cells","volume":"8","author":"Espagnolle","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0740","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2021.102755_bb0745","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045272","article-title":"Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway","volume":"7","author":"Luz-Crawford","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0755","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.autrev.2021.102755_bb0760","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.4049\/jimmunol.175.10.6352","article-title":"Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors","volume":"175","author":"Poggi","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0765","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0770","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/14653249.2010.523077","article-title":"Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways","volume":"13","author":"G\u00f6therstr\u00f6m","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0775","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1089\/ten.tea.2008.0630","article-title":"Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells","volume":"15","author":"DelaRosa","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.autrev.2021.102755_bb0780","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing","volume":"14","author":"Francois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0785","first-page":"117","article-title":"Induction of regulatory B-cells by mesenchymal stem cells is affected by SDF-1\u03b1-CXCR7","volume":"37","author":"Qin","year":"2015","journal-title":"CPB"},{"key":"10.1016\/j.autrev.2021.102755_bb0790","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","article-title":"Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells","volume":"116","author":"Gieseke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0795","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/ijo.2010.869","article-title":"Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins","volume":"38","author":"Sioud","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.autrev.2021.102755_bb0800","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3858\/emm.2009.41.5.035","article-title":"Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10","volume":"41","author":"Yang","year":"2009","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0805","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","article-title":"Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta","volume":"184","author":"Patel","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0810","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0815","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/cells9071660","article-title":"Mechanisms behind the immunoregulatory dialogue between mesenchymal stem cells and Th17 cells","volume":"9","author":"Terraza-Aguirre","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0820","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009252","article-title":"Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile","volume":"5","author":"Maggini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0830","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.celrep.2020.01.047","article-title":"CCL2 and CXCL12 derived from mesenchymal stromal cells cooperatively polarize IL-10+ tissue macrophages to mitigate gut injury","volume":"30","author":"Giri","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0835","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102755_bb0840","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2021.102755_bb0845","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.4049\/jimmunol.1300194","article-title":"TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8","volume":"192","author":"Dyer","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0850","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0855","doi-asserted-by":"crossref","first-page":"38207","DOI":"10.1038\/srep38207","article-title":"Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD","volume":"6","author":"Kennelly","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0860","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136059","article-title":"Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammation","volume":"5","author":"Lee","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2021.102755_bb0865","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.stemcr.2013.06.006","article-title":"Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor\/c-Met and STAT3","volume":"1","author":"Yen","year":"2013","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0870","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2021.102755_bb0875","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcyt.2018.02.372","article-title":"Mesenchymal stromal cell exosome\u2013enhanced regulatory T-cell production through an antigen-presenting cell\u2013mediated pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0880","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00125-015-3808-0","article-title":"Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients","volume":"59","author":"Favaro","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2021.102755_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00771","article-title":"Mesenchymal stromal cells and their extracellular vesicles enhance the anti-inflammatory phenotype of regulatory macrophages by downregulating the production of interleukin (IL)-23 and IL-22","volume":"9","author":"Hyv\u00e4rinen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0890","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.1900692","article-title":"Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer","volume":"203","author":"Biswas","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-02788-0","article-title":"IFN-\u03b3 promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb0900","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00149","article-title":"Mesenchymal stem cell-derived extracellular vesicles: challenges in clinical applications","volume":"8","author":"Gowen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.autrev.2021.102755_bb0905","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/stem.2372","article-title":"Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS","volume":"34","author":"Jackson","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb0910","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1038\/ncomms9472","article-title":"Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs","volume":"6","author":"Phinney","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.102755_bb0915","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948052","article-title":"Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response","volume":"21","author":"Court","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0920","series-title":"Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity","first-page":"e438","volume":"104","author":"Cheung","year":"2019"},{"key":"10.1016\/j.autrev.2021.102755_bb0925","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2021.102755_bb0930","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13287-015-0233-8","article-title":"A robust potency assay highlights significant donor variation of human mesenchymal stem\/progenitor cell immune modulatory capacity and extended radio-resistance","volume":"6","author":"Ketterl","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0935","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcyt.2018.10.014","article-title":"Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency","volume":"21","author":"Robb","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0940","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.celrep.2018.02.013","article-title":"Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach","volume":"22","author":"Chinnadurai","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0945","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/bloodadvances.2020001711","article-title":"Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match","volume":"4","author":"Giri","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.autrev.2021.102755_bb0950","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jcyt.2015.08.008","article-title":"Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency","volume":"17","author":"Salem","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2021.102755_bb0955","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.celrep.2018.02.013","article-title":"Potency analysis of mesenchymal stromal cells using a combinatorial assay matrix approach","volume":"22","author":"Chinnadurai","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2021.102755_bb0960","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000114522.38265.61","article-title":"Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives","volume":"109","author":"Planat-Benard","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2021.102755_bb0965","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","article-title":"Mesenchymal stem cells can be differentiated into endothelial cells in vitro","volume":"22","author":"Oswald","year":"2004","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.autrev.2021.102755_bb0970","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13287-016-0418-9","article-title":"Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta","volume":"7","author":"Du","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb0975","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072604","article-title":"Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis","volume":"8","author":"Hsieh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0980","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","article-title":"Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms","volume":"94","author":"Kinnaird","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2021.102755_bb0985","article-title":"Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035685","article-title":"Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis","volume":"7","author":"Boomsma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb0995","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb1000","doi-asserted-by":"crossref","first-page":"16317","DOI":"10.1016\/S0021-9258(18)42003-0","article-title":"Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways","volume":"267","author":"Claffey","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102755_bb1005","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.autrev.2021.102755_bb1010","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1253\/circj.CJ-11-0246","article-title":"Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow","volume":"75","author":"Nakanishi","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.autrev.2021.102755_bb1015","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1089\/scd.2011.0674","article-title":"Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue","volume":"21","author":"Hsiao","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.autrev.2021.102755_bb1020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10456-010-9194-9","article-title":"Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms","volume":"14","author":"Kachgal","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.autrev.2021.102755_bb1025","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","article-title":"Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms","volume":"109","author":"Kinnaird","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2021.102755_bb1030","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jbiomech.2009.11.030","article-title":"Endothelium oriented differentiation of bone marrow mesenchymal stem cells under chemical and mechanical stimulations","volume":"43","author":"Bai","year":"2010","journal-title":"J Biomech"},{"key":"10.1016\/j.autrev.2021.102755_bb1035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCRESAHA.107.159475","article-title":"A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks","volume":"102","author":"Traktuev","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2021.102755_bb1040","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/CIRCRESAHA.108.190926","article-title":"Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells","volume":"104","author":"Traktuev","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2021.102755_bb1045","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1089\/ten.tea.2009.0635","article-title":"Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation","volume":"16","author":"Merfeld-Clauss","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.autrev.2021.102755_bb1050","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCRESAHA.115.304026","article-title":"Adipose stromal cells differentiate along a smooth muscle lineage pathway upon endothelial cell contact via induction of activin A","volume":"115","author":"Merfeld-Clauss","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2021.102755_bb1055","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/stem.2074","article-title":"Adipose stromal cell contact with endothelial cells results in loss of complementary vasculogenic activity mediated by induction of activin A","volume":"33","author":"Merfeld-Clauss","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb1060","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1095\/biolreprod.109.081828","article-title":"Paracrine factors from human placental multipotent mesenchymal stromal cells protect endothelium from oxidative injury via STAT3 and manganese superoxide dismutase activation","volume":"82","author":"Liu","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.autrev.2021.102755_bb1065","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/jcp.22548","article-title":"Role of the EGFR ligand\/receptor system in the secretion of angiogenic factors in mesenchymal stem cells","volume":"226","author":"De Luca","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2021.102755_bb1070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181946","article-title":"Multipotent mesenchymal stem cells in lung fibrosis","volume":"12","author":"Hostettler","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102755_bb1075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/BOR.0b013e32834b1606","article-title":"New insights on chemically induced animal models of systemic sclerosis","volume":"23","author":"Batteux","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb1080","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2021.102755_bb1085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1465-9921-11-16","article-title":"Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury\/fibrosis","volume":"11","author":"Lee","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2021.102755_bb1090","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.transproceed.2008.01.080","article-title":"Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats","volume":"40","author":"Zhao","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2021.102755_bb1095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1165\/rcmb.2004-0330OC","article-title":"Bone marrow-derived mesenchymal stem cells in repair of the injured lung","volume":"33","author":"Rojas","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2021.102755_bb1100","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1002\/jcp.26418","article-title":"Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing","volume":"233","author":"Rubio","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2021.102755_bb1105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","article-title":"Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury","volume":"175","author":"Moodley","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2021.102755_bb1110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.apjtm.2016.10.005","article-title":"Adipose tissue-derived stem cells ameliorates dermal fibrosis in a mouse model of scleroderma","volume":"10","author":"Chen","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.autrev.2021.102755_bb1115","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb1120","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3389\/fimmu.2018.02571","article-title":"Fibrosis development in HOCl-induced systemic sclerosis: a multistage process hampered by mesenchymal stem cells","volume":"9","author":"Maria","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb1125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2016.03.013","article-title":"Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis","volume":"70","author":"Maria","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102755_bb1130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.39477","article-title":"Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis","volume":"68","author":"Maria","year":"2016","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.autrev.2021.102755_bb1135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1634\/stemcells.2006-0243","article-title":"In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models","volume":"25","author":"Meyerrose","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.autrev.2021.102755_bb1140","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","article-title":"In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis","volume":"38","author":"Gholamrezanezhad","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.autrev.2021.102755_bb1145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.autrev.2021.102755_bb1150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11684-011-0114-1","article-title":"Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms","volume":"5","author":"Li","year":"2011","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2021.102755_bb1155","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.autrev.2021.102755_bb1160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","article-title":"Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis","volume":"67","author":"Larghero","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102755_bb1165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","article-title":"Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro","volume":"46","author":"Bocelli-Tyndall","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102755_bb1170","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.22035","article-title":"Bone marrow endothelial progenitors are defective in systemic sclerosis","volume":"54","author":"Del Papa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb1175","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb1180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001890","article-title":"Expression of transforming growth factor beta receptor II in mesenchymal stem cells from systemic sclerosis patients","volume":"3","author":"Vanneaux","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2021.102755_bb1185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cei.12111","article-title":"Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy","volume":"173","author":"Cipriani","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102755_bb1190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-016-0444-7","article-title":"Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine","volume":"8","author":"Griffin","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2021.102755_bb1195","doi-asserted-by":"crossref","unstructured":"Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, et al. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 70:2011\u201321.","DOI":"10.1136\/ard.2011.150607"},{"key":"10.1016\/j.autrev.2021.102755_bb1200","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2021.102755_bb1205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/s10165-010-0274-x","article-title":"Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells","volume":"20","author":"Ishigatsubo","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2021.102755_bb1210","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","article-title":"Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L","volume":"22","author":"Christopeit","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.autrev.2021.102755_bb1215","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102755_bb1220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13075-017-1373-2","article-title":"Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis","volume":"19","author":"Zhang","year":"2017","journal-title":"Arthritis Res Ther"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:20:14Z","timestamp":1761600014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":244,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1568997221000148"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102755","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells for systemic sclerosis treatment","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102755"}}